Comparative study of vascular endothelial growth factor receptor-2 expression in spinal tumors
Keywords:
vascular endothelial growth factor, spinal tumors, vascular malformationsAbstract
The vascular endothelial growth factor receptor-2 (KDR) expression in various tumors and vascular malformations of spinal cord was investigated.
The KDR mRNA was detected in all tumor tissues examined. However, we found different degree of VEGF receptor-2 expression in various tumor tissue samples. The highest expression was observed in the metastatic tumors and schwannomas. The KDR expression in vascular tumour and malformation was less pronounced. The meningiomas fall in category of tumour with small expression of VEGF receptor-2 (KDR).
References
Клеменс М. Выделение эукариотической матричной РНК (мРНК) // Транскрипция и трансляция. Методы. Пер. с англ./ Под ред.Б.Хеймса и С.Хиггинса.— М.:Мир, 1987. — С.254—275.
Abdulrauf S.I., Edvardsen K., Ho K.L., et al. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma // J Neurosurg. —1998. — V.88. —P.513—520.
Agani F., Kirsch D.G., Friedman S.L., et al. p53 does not repress hypoxia-induced transcription of the vascular endothelial growth factor gene // Cancer Res. —1997. — V.57. —P.4474—4477.
Amoroso A., Del Porto F., Di Monaco C., et al. Vascular endothelial growth factor: a key mediator of neoangiogenesis. A review // Europ. Rev. Med. Pharmacol. Sci. — 1997.-V1. —P.17—25.
Bartholdi D., Rubin B.P., Schwab M.E. VEGF mRNA induction correlates with changes in the vascular architecture upon spinal cord damage in the rat // Europ. J. Neurosci. —1997. —V. —9. —P2549—2550.
Crew J.P., O’Brien T., Bradburn M., et al. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer // Cacer. Res. —1997. —V.57. —P.5281—5285.
D’Angelo G., Lee H., Weiner R.I. cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation // J. Cell. Biochem. —1997. —V.67. —P.353—366.
Dietzmann K., von Bossanyi P., Warich-Kirches M., et al. Immunohistochemical detection of vascular growth factors in angiomatous and atypical meningiomas, as well as hemangiopericytomas // Pathol. Res. Pract. —1997. —V.193. —P503—510.
Ergun S., Luttmer W., Fiedler W., Holstein A.F. Functional expression and localization of vascular endothelial growth factor and its receptors in the human epididymis // Biol. Reprod. —1998. —V58. —P160—168.
Kang S.M., Maeda K., Onoda N., et al. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis // Int. J. Cancer—1997. —V74. —P502—507.
Maeno N., Takei S., Imanaka H., et al. Increased circulating vascular endothelial growth factor is correlated with disease activity in polyarticular juvenile rheumatoid arthritis // J. Rheumatol. —1999. —V26. —P2244—2248.
Miura H.,MiyazakiT., Kuroda M., et al. Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma // J. Hepatol. —1997. — V.27. —P.854—861.
Papapetropoulos A., Garcнa-Cardeсa G., Madri J.A., Sessa W.C. Nitric Oxide Production Contributes to the Angiogenic Properties of Vascular Endothelial Growth Factor in Human Endothelial Cells // J. clin. Invest .— 1997. —V.100—P. 3131—3139.
Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: A laboratory manual. —ColdSpringHarborLaboratory Press, 2nd ed.,1989. —485 p.
Shibuya M., Yamaguchi S., Yamane A., Ikeda T. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family // Oncogene. — 1990. —V.5. —P.519—524.
Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts //Brain Res. —1999. —V846, —P.219—228.
Stratmann R., Krieg M., Haas R., Plate K.H. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene // J. Neuropath. exp. Neurol. —1997. —V.56. —P.1242—1252.
Terman B.I., Dougher-Vermazen M.,CarrionM.E., Dimitrov D. Identification of the KDR tyrosine kinase as a receptor for vascular endotelial cell growth factor //Biochem. biophys. Res. Commun. —1992. —V.187. —P.1579—1586.
Tischer, E., Mitchell R., Hartman T., et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing //J. biol. Chem. —1991. —V.266. —P.11947—11954.
Vaquero J., Zurita M., de Oya S., Coca S. Vascular endothelial growth/ permeability factor in spinal cord injury // J. Neurosurg. — 1999. —V.90. —P.220—223.
Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts// Brain Res. — 1999. —V.846. —P.219—228.
Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system //. J. Neurol. Sci. —1999. —V.19. —P.5731—5740.
Richard S., Campello C., Taillandier L., et al. Haemangioblastoma of the central nervous system in von Hippel-Lindau disease. French VHL Study Group //J. Intern. Med. —1998. —V. 243. —P.547—553.
Leung S.Y., Chan A.S., Wong M.P., et al. Expression of vascular endothelial growth factor and its receptors in pilocytic astrocytoma //Am. J. Surg. Pathol. —1997. —V.21. —P.941—950.
Wizigmann-Voos S., Plate K.H. Pathology, genetics and cell biology of hemangioblastomas //Histol. Histopathol. —1996. —V.11—P.1049—1061.
Bohling T., Hatva E., Kujala M., et al. Expression of growth factors and growth factor receptors in capillary hemangioblastoma //J. Neuropath. exp. Neurol. —1996. —V.55. —P.522—527.
Li Q.F., Reis E.D., Zhang W.X., et al. Accelerated flap prefabrication with vascular endothelial growth factor //J. Reconstr. Microsurg. —2000. —V.16. —P.45—49.
Zhu Z., Witte L. Inhibition of tumor growth and metastasis by targeting tumor-associated angiogenesis with antagonists to the receptors of vascular endothelial growth factor //Invest. New. Drugs. —1999. —V.17. —P:195—212.
Wong E.Y., Morgan L., Smales C., et al. Vascular endothelial growth factor stimulates dephosphorylation of the catenins p120 and p100 in endothelial cells //Biochem J. —2000. —V.15. —P.209—216.
Chow N.H., Liu H.S., Chan S.H., et al. Expression of vascular endothelial growth factor in primary superficial bladder cancer //Anticancer Res. — 1999. —V.19. —P.4593—4597.
Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors //Blood —2000. —V.95. —P.952—958.
Rowe D.H., Huang J., Kayton M.L., et al. Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms’ tumor //J. pediat. Surg. —2000. —V.35. —P.30—32.
Jyung R.W., LeClair E.E., Bernat R.A., et al. Expression of angiogenic growth factors in paragangliomas // Laryngoscope —2000. —V.110. —P.161—167.
Zhou J., Tang Z.Y., Fan J., et al. Expression of platelet-derived endothelial cell growth factor and vascular endothelial growth factor in hepatocellular carcinoma and portal vein tumor thrombus //J. Cancer. Res. Clin. Oncol. — 2000. —V. 126. —P.57—61.
Seto S., Onodera H., Kaido T., et al. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis //Cancer. —2000. —V.88. —P.295—301.
Banerjee S.K., Zoubine M.N., Tran T.M., et al. Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 inestrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells //Int. J. Oncol. — 2000. — V.16. —P.253—260.
Uranishi R., Nakase H., Sakaki T. Expression of angiogenic growth factors in dural arteriovenous fistula //J. Neurosurg. —1999. —V.91. —P.781—786.
Homer J.J., Anyanwu K., Ell S.R., et al. Serum vascular endothelial growth factor in patients with head and neck squamous cell carcinoma //Clin. Otolaryngol. —1999. —V.24. —P.426—430.
Graeven U., Fiedler W., Karpinski S et al. Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR //J. Cancer. Res. Clin. Oncol. —1999. —V.125. —P.621—629.
Prewett M., Huber J., Li Y., et al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors //Cancer. Res. — 1999. —V.59. —P.5209—5218.
Gabrilovich D.I., Ishida T., Nadaf S., et al. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function //Clin. Cancer. Res. —1999. —V.5. —P.2963—2970.
Wynendaele W., Derua R., Hoylaerts M.F., et al. Vascular endothelial growth factor measured in platelet poor plasma allows optimal separation between cancer patients and volunteers: a key to study an angiogenic marker in vivo? //Ann. Oncol. —1999. —V.10. —P.965—971.
Carroll R.S., Zhang J., Bello L., et al. KDR activation in astrocytic neoplasms//Cancer.—1999. —V.86. —P.1335—1341.
Christov C., Lechapt-Zalcman E., Adle-Biassette H., et al. Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 inmicrocystic meningiomas //Acta Neuropathol. (Berl.) —1999. —V.98. —P.414—420.
Holash J., Wiegand S.J., Yancopoulos G.D. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF //Oncogene .—1999. —V.18. —P.5356—5362.
Meister B., Grunebach F., Bautz F., et al. Expression of vascular endothelial growth factor (VEGF) and its receptors in human neuroblastoma //Eur. J. Cancer. —1999. — V.35. —P.445—449.
Harada H., Nakagawa K., Iwata S et al. Restoration of wild-type p16 down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human gliomas //Cancer Res.— 1999.—V.59.—P.3783—3789.
Vaquero J., Zurita M., Coca S., et al. Expression of vascular endothelial growth factor in cerebellar hemangioblastomas does not correlate with tumor angiogenesis //Cancer Lett. —1998.—V.23.—P.213—217.
Altenschmidt U., Kahl R., Klundt E., et al. Schwannoma cells induce a tumor-cell-specific cytotoxic-T-cell response upon transplantation into syngeneic rats but escape elimination through the secretion of immunosuppressive factors //Int. J .Cancer. —1997. —V.70.—P.542—550.
Gridley D.S., Loredo L.N., Slater J.D et al. Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor //Cancer Detect. Prev. —1998. —V.22.—P.20—29.
Angelov L., Salhia B., Roncari L., et al. Inhibition of angiogenesis by blocking activation of the vascular endothelial growth factor receptor 2 leads to decreased growth of neurogenic sarcomas //Cancer Res. — 1999. —V.59.—P.5536—5541.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2001 Yuriy Zozulya, Irina Vasileva, Eugene Slynko, Nataliya Chopik
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.
